Peliosis hepatis associated with androgenic-anabolic steroid therapy. A severe form of hepatic injury.
D000328:Adult; D000368:Aged; D045930:Anabolic Agents / Q000009:adverse effects*; D000728:Androgens / Q000009:adverse effects*; D000741:Anemia, Aplastic / Q000188:drug therapy; D001344:Autopsy; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D005474:Fluoxymesterone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008099:Liver / Q000473:pathology; D008297:Male; D008777:Methyltestosterone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D009639:Norethandrolone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010110:Oxymetholone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011693:Purpura / Q000139:chemically induced*; D013739:Testosterone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D045930:Anabolic Agents; D000728:Androgens; D013739:Testosterone; D005474:Fluoxymesterone; D010110:Oxymetholone; D009639:Norethandrolone; D008777:Methyltestosterone